Transgene (XPAR:TNG) Days Inventory: (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:TNG Transgene SA XPAR:TNG
41 GF Score
Price €0.86
GF Value €0.50
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Transgene Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Transgene's Average Total Inventories for the six months ended in Dec. 2025 was €0.00 Mil. Transgene's Cost of Goods Sold for the six months ended in Dec. 2025 was € Mil.

The historical rank and industry rank for Transgene's Days Inventory or its related term are showing as below:

XPAR:TNG's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 184.675
* Ranked among companies with meaningful Days Inventory only.

Transgene's Days Inventory stayed the same from Dec. 2024 () to Dec. 2025 ().

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Transgene's Inventory-to-Revenue for the six months ended in Dec. 2025 was 0.00.

Transgene  (XPAR:TNG) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Transgene's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
= / 0
=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Transgene's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 0.041
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Transgene Days Inventory Related Terms

Transgene Days Inventory Historical Data

* Premium members only.

The historical data trend for Transgene's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgene Days Inventory Chart

Transgene Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Transgene Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

XPAR:TNG vs VRTX, REGN, MRNA: Days Inventory Comparison

For the Biotechnology subindustry, Transgene's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transgene Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgene's Days Inventory distribution charts can be found below:

* The bar in red indicates where Transgene's Days Inventory falls into.


XPAR:TNG
41GF Score
Transgene SA XPAR:TNG
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgene Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Transgene's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / *365
=0 / *365
=N/A

Transgene's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Transgene (XPAR:TNG) Overvalued in 2026?

Based on GuruFocus' analysis, Transgene stock appears to be overvalued. The current stock price of €0.86 is trading 72% above its estimated GF Value™ of €0.50. GuruFocus considers Transgene to be Significantly Overvalued.

Key valuation signals for XPAR:TNG:

  • Days Inventory:
  • GF Value™: €0.50 vs. price of €0.86 (72% above fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the XPAR:TNG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgene Business Description

Address 400, Boulevard Gonthier d’Andernach, Parc d’Innovation, Illkirch-Graffenstaden, Strasbourg, FRA, 67400
Transgene SA is a biotechnology company that designs and develops virus based immunotherapy products focused on the development of individualized therapeutic vaccines against cancers. The flagship program, TG4050, is an individualized therapeutic vaccine based on the myvac platform. The company also has other viral vector-based programs, including BT-001, an oncolytic virus based on the Invir.IO viral backbone, which is in clinical development. In addition, it conducts discovery and preclinical work, aimed at developing novel immunotherapies.
41GF Score

Get the complete analysis for XPAR:TNG

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€0.50
GF Value